Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20-80
SponsorKaohsiung Veterans General Hospital.
About this trial
This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
Eligibility criteria
Qualifiers
Subjects are between 20-80 years old.
Anesthesiologists rated ASA as between I and III.
Patients undergoing upper gastrointestinal endoscopic examination or therapy.
Disqualifiers
Allergy to Propofol, Remimazolam, or opioid medications.
Emergency surgery.
Pregnancy.
History of malignant hyperthermia.
Trial design
Treatments tested in this trial
- Remimazolam
- Propofol
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov